The startup manufactures treatment devices for dry eye disease that stimulate the trigeminal parasympathetic pathway to enhance tear film production. This technology enables healthcare professionals to effectively manage chronic dry eye conditions in patients.
Funding
$8.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals experience dry eye symptoms, such as gritty, itchy, and tired eyes, due to insufficient tear production or poor tear film quality. Traditional treatments often rely on eye drops or drugs, which may not address the underlying cause or provide long-lasting relief.
Solution
Olympic Ophthalmics offers iTEAR®100, a drug-free, drop-free, FDA-cleared medical device that stimulates the external nasal nerve to enhance natural tear production. The iTEAR®100 device uses focused oscillatory energy to activate the trigeminal parasympathetic pathway, which in turn stimulates the glands responsible for tear film production. This handheld, battery-powered device is applied externally to the nose for 30 seconds, providing immediate and sustained relief from dry eye symptoms by increasing the production of the patient's own natural tears. The device is reusable and does not require replacement parts.
Target Audience
The primary target audience includes individuals experiencing dry eye symptoms, as well as ophthalmologists and optometrists seeking a drug-free, drop-free treatment option for their patients.
Features
- Patented technology using focused oscillatory energy to stimulate the external nasal nerve
- Optimized energy level, frequency, and tip design based on clinical trials
- Drug-free and drop-free solution for dry eye
- Simple, at-home use with immediate results
- Portable and battery-powered with USB-rechargeable battery
- Reusable device with no replacement parts needed
- External application to the nose
- Prescription-based device